IL28RA expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.274799486088E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.98770000459092E-09 |
Normal-vs-Stage2 |
4.04190000358184E-08 |
Normal-vs-Stage3 |
9.82325332188339E-13 |
Normal-vs-Stage4 |
7.44948547293234E-12 |
Stage1-vs-Stage2 |
1.422790E-01 |
Stage1-vs-Stage3 |
1.423900E-03 |
Stage1-vs-Stage4 |
2.837300E-04 |
Stage2-vs-Stage3 |
3.718400E-01 |
Stage2-vs-Stage4 |
1.308010E-01 |
Stage3-vs-Stage4 |
4.422200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.87289977865635E-10 |
Normal-vs-AfricanAmerican |
1.1814999999471E-06 |
Normal-vs-Asian |
1.912630E-01 |
Caucasian-vs-AfricanAmerican |
6.075200E-01 |
Caucasian-vs-Asian |
1.977770E-01 |
AfricanAmerican-vs-Asian |
2.690400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.81029977067249E-10 |
Normal-vs-Female |
4.37800018460166E-10 |
Male-vs-Female |
3.151000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.57119999630606E-08 |
Normal-vs-Age(41-60Yrs) |
4.01769995050927E-09 |
Normal-vs-Age(61-80Yrs) |
2.58748578119139E-12 |
Normal-vs-Age(81-100Yrs) |
1.904660E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.054220E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.904980E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.427190E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.263200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.997000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.234400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.633600E-01 |
Normal-vs-Grade 2 |
7.98490000009089E-07 |
Normal-vs-Grade 3 |
2.64310018316394E-10 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
8.648000E-02 |
Grade 1-vs-Grade 3 |
6.217200E-03 |
Grade 1-vs-Grade 4 |
1.897850E-03 |
Grade 2-vs-Grade 3 |
2.800200E-03 |
Grade 2-vs-Grade 4 |
1.63880020664919E-12 |
Grade 3-vs-Grade 4 |
1.35740000017925E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.7725199999985E-05 |
Normal-vs-ccB subtype |
1.64646074551911E-12 |
ccA subtype-vs-ccB subtype |
2.65332200655166E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.05691019772303E-12 |
Normal-vs-N1 |
2.88209999999012E-06 |
N0-vs-N1 |
7.877500E-02 |
|
|